Bir Hemodiyaliz Hastasında Metastatik Staphylococcus Aureus Enfeksiyonu

Yıl 2025, Cilt: 10 Sayı: 3, 96 - 98, 31.12.2025

Davut Eren , Onur Tatar , Sümeyra Koyuncu

https://doi.org/10.55694/jamer.1610319

Öz

Metisiline dirençli Staphylococcus aureus (MRSA), antibiyotik direnci nedeniyle tedavisi zor ve yüksek ölüm oranlarına sahip invaziv enfeksiyonlara neden olmaktadır. Sık hastaneye yatış, antibiyotik kullanımı, invaziv kateterler ve hemodiyaliz MRSA enfeksiyonları için risk faktörleridir. Burada, MRSA'nın neden olduğu pnömoni ve bakteriyemisi olan bir hemodiyaliz hastası bildirilmektedir.

Anahtar Kelimeler

Staphylococcus aureus , hemodiyaliz , pnömoni

Metastatic Staphylococcus Aureus Infection in a Haemodialysis Patient

Öz

Methicillin-resistant Staphylococcus aureus (MRSA) causes invasive infections that are difficult to treat and have high mortality rates due to antibiotic resistance. Frequent hospitalization, antibiotic use, invasive catheters, and hemodialysis are risk factors for MRSA infections. Here, we report a hemodialysis patient with pneumonia and bacteremia caused by MRSA.

Anahtar Kelimeler

Staphylococcus aureus , haemodialysis , pneumonia

Kaynakça

• 1. Rasigade JP, Vandenesch F. Staphylococcus aureus: a pathogen with still unresolved issues. Infect Genet Evol. 2014 Jan;21:510-514.
• 2. Liu A, Garrett S, Hong W, Zhang J. Staphylococcus aureus Infections and human intestinal microbiota. Pathogens. 2024; 13(4):276.
• 3. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28(3):603-661.
• 4. Turner NA, Sharma-Kuinkel BK, Maskarinec SA, Eichenberger EM, Shah PP, Carugati M, et al. Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research. Nat Rev Microbiol. 2019 Apr;17(4):203-218.
• 5. Siddiqui AH, Koirala J. Methicillin-resistant staphylococcus aureus. [Updated 2023 Apr 2]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan . Available from: https://www. ncbi.nlm.nih.gov/books/NBK482221/
• 6. Li Z, Zhuang H, Wang G, Wang H, Dong Y. Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant staphylococcus aureus in patients with malignancy: systemic review and meta-analysis. BMC Infect Dis 2021 14;21(1):74.
• 7. Nyasinga J, Munshi Z, Kigen C, Nyerere A, Musila L, Whitelaw A, et al. Displacement of hospital-acquired, methicillin-resistant staphylococcus aureus clones by heterogeneous community strains in Kenya over a 13-Year Period. Microorganisms. 2024; 12(6):1171.
• 8. European Centre for Disease Prevention and Control/European Medicines Agency (ECDC/EMEA). Joint technical report The bacterial challenge: time to react. Stockholm:ECDC/EMEA; 2009.
• 9. Murdeshwar HN, Anjum F. Hemodialysis. [Updated 2023 Apr 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/ NBK563296/
• 10. Kwiecinski JM, Jacobsson G, Horswill AR, Josefsson E, Jin T. Biofilm formation by staphylococcus aureus clinical isolates correlates with the infection type. Infect Dis (Lond). 2019 Jun;51(6):446-451.
• 11. Kaushik A, Kest H, Sood M, Steussy BW, Thieman C, Gupta S. Biofilm producing methicillin-resistant staphylococcus aureus (MRSA) infections in humans: Clinical Implications and Management. Pathogens. 2024; 13(1):76.
• 12. Karkar A. Infection control guidelines in hemodialysis facilities. Kidney Res Clin Pract. 2018;37(1):1-3.